Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03610269 · ClinicalTrials.gov registry record · NA
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
A NA study of Anemia, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 143
- Enrollment target
- 1
- Study location
NCT03610269 is a NA study of Anemia that has completed, run by Masimo Corporation. The registered enrollment target is 143 participants, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03610269, a NA study of Anemia, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this clinical investigation is to evaluate the accuracy of using Masimo's INVSENSOR00026 Pulse CO-Oximeter and Sensor to measure hemoglobin, as compared to hemoglobin measurements obtained from various lab analyzer(s) and point of care device(s).
Conditions Studied
Interventions
- DEVICE INVSENSOR00026 (Pulse CO-Oximeter and sensor)
Study Locations (1)
California
- Torrance Clinical Research - Lomita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2018-08-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03610269
The ClinicalTrials.gov registry entry for NCT03610269 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (66% lower). The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which INVSENSOR00026 (Pulse CO-Oximeter and sensor) is the first listed.
NCT03610269 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03610269 about?
NCT03610269 is a clinical study titled "Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026". The primary objective of this clinical investigation is to evaluate the accuracy of using Masimo's INVSENSOR00026 Pulse CO-Oximeter and Sensor to measure hemoglobin, as compared to hemoglobin measurements obtained from various lab analyzer(s) and point of care device(s).
What is the current status of trial NCT03610269?
This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2018-08-01. Estimated completion is 2018-08-16.
What conditions does trial NCT03610269 study?
This clinical trial studies the following conditions: Anemia.
What interventions are being tested in trial NCT03610269?
The interventions under investigation include: INVSENSOR00026 (Pulse CO-Oximeter and sensor) (DEVICE).
Who is sponsoring clinical trial NCT03610269?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03610269 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
-
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
RECRUITING · NA
-
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
RECRUITING · NA
-
The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
ACTIVE NOT RECRUITING · NA
-
Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia
ACTIVE NOT RECRUITING · NA
-
Placental Transfusion in Term Infants: A Pilot Study
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.